CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2024 Earnings Call Transcript March 6, 2025
CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $-0.23.
Operator: Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics, Fourth Quarter 2024 financial results call. Please be advised that today’s call is being recorded. I would now like to hand the call over to your host for today, Chris Ogden, CytomX’s Chief Financial...
